Gum treatment and asprosin in stable angina
Part of Bones, joints & muscles, Genetic & congenital, Heart & circulation, Mouth & dental, Pain clinical trials.
This study tests whether treating gum disease can affect a protein called asprosin in people with stable angina (chest pain from heart disease). It may help show if gum treatment can improve heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be willing to join and sign a consent form
- No gum treatment in the past 6 months
- No antibiotics (pills or applied to gums) in the past 3 months
- No heart attack in the past 6 months
- If female, not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a standard deep-cleaning treatment for gum disease can improve heart health in people with stable angina. It may help by reducing inflammation that can affect your heart.
This trial tests whether intensive gum disease treatment can improve health in people with aortic stenosis (a narrowed heart valve). If you have both gum disease and mild-to-moderate aortic stenosis, you may be able to join.
This study tests a standard deep-cleaning gum treatment in people who have both gum disease and well-controlled high blood pressure. The researchers will check the levels of certain proteins in your gum fluid to see if the treatment helps reduce inflammation, which might also benefit your blood pressure.
This study tests whether treating moderate to severe gum disease can lower your risk of heart disease and stroke. You would receive non-surgical gum treatment and be followed over time to see how it affects your heart health.
This trial tests whether an anti-inflammatory diet can improve the results of standard gum disease treatment. It is for people diagnosed with periodontitis who are otherwise healthy and do not smoke.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
Hear when a new Stable Angina Pectoris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.